OncoGenex opened Monday at., and fell percent to. 온코 제 넥스는 12 월부터 투자자들의 열광적 인 관심을 끌었습니다. OncoGenex has attracted a frenzy of investor interest since Dec.. Thats the day it released striking results that its experimental drug, OGX, was able to extend the lives of prostate cancer patients by a median time of.